Endothelial progenitor cells (EPCs) are a group of heterogeneous cells in bone marrow (BM) and blood. Ischaemia increases reactive oxygen species (ROS) production that regulates EPC number and function. The present study was conducted to determine if ischaemia-induced ROS differentially regulated individual EPC subpopulations using a mouse model concomitantly overexpressing superoxide dismutase These data suggested that ischaemia-induced ROS was differentially involved in the regulation of circulating EPC population.
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| INTRODUC TI ON
Formation of new blood vessels (neovascularization) is an important mechanism in response to ischemic injuries/conditions such as ischemic heart disease and peripheral artery disease. 1, 2 Bone marrow (BM)-derived endothelial progenitor cells (EPCs) play a critical role in vascular re-endothelialization, angiogenesis and prevention of neointima formation after vascular injury. 1, 2 However, EPCs are a group of very heterogeneous cell population with a variety of different cell markers reported in the literature. 3 There are also multiple sources for EPCs with BM and blood as the two major EPC sources. 4 Reactive oxygen species (ROS) such as superoxide anion (O 2   -) and hydrogen peroxide (H 2 O 2 ) are critically involved in cell growth, migration, differentiation, apoptosis and senescence. 5, 6 It has been reported that increased amounts of ROS is produced in response to tissue ischaemia. 8 Although high concentrations of ROS are involved in senescence and apoptosis of endothelial cells and stem/progenitor cells and associated with defective neovascularization, 9,10 low levels of ROS generated during tissue ischaemia serve as intracellular signals to trigger angiogenesis. 11, 12 The effects of ROS following limb ischaemia on EPCs are reported to be mainly through Nox2-containing NADPH oxidase. 10, 13, 14 However, the changes in specific subpopulations of EPCs in response to ROS formation during limb ischaemia have not been studied. It has been reported that ROS production in BM derived mononuclear cells is associated with the number of EPC. 14 Many antioxidant enzymes including copper-zine superoxide dismutase (SOD1) in the cytoplasm, 16 extracellular SOD (SOD3) 17, 18 and glutathione peroxidase (Gpx-1) 19 23 Our previous study showed that concomitant overexpression of SOD1, SOD3 and Gpx-1 had no measurable effect on the basal ROS level and baseline EPC populations in either BM or circulation. 23 As the basal levels of ROS and EPC populations were low in mice, limb ischaemia was induced by femoral artery ligation (FAL) to increase ROS production and EPC levels.
Although a variety of pathological conditions such as hyperlipidaemia, diabetes mellitus and infection could increase ROS generation, 24, 25 we used the limb ischaemia model in consideration of the important role of EPCs in angiogenesis and vascular repair after ischemic injuries. As there were no unified cell markers for EPCs, we used four different groups of cell markers to identify EPCs to ensure a comprehensive analysis of EPCs in BM and blood. mice as the control as detailed previously. 27 Successful creation of the TG mice was confirmed with genotyping ( Figure S1A ) and increased protein expression of the enzymes (using western blot analysis) ( Figure S1B ) as well as increased enzyme activities as described. 22, 23 Of note, the antibodies for SOD-1 (Invitrogen, Catalogue: MA1-105), SOD-3 (Santa Cruz, Catalogue: sc-376948)
| MATERIAL S AND ME THODS

| Animal models
and Gpx-1 (Invitrogen, Catalogue: 702762) used for the present study were cross-reactive with the respective proteins from both human and mouse. Thus, the basal expression levels for these three enzymes were detectable in the wild-type littermate ( Figure S1B ).
| Hind limb ischaemia and blood flow measurement
FAL was performed to produce hind limb ischaemia in the mice as described. 28 Mice were anaesthetized with one dose of 
| Treadmill performance
Wild-type C57BL/6J and TG male mice were subjected to a treadmill running test following a protocol modified from that of Massett and Berk. 29 Mice were placed on a rodent treadmill equipped with an electric grid at the rear and were made to run continuously until exhaustion at day 7, 14 and 21 after limb ischaemia (indicated by falling on the electric grid twice) and the running time on the treadmill was recorded. Two separate trials with eight WT and eight TG mice per trial were conducted. Both TG and WT mice were able to run more than 400 minutes at baseline before limb ischaemia. scribed. 30, 31 Capillaries were counted using the Image J software.
| CD31
| Intracellular ROS detection
BM and blood cells were harvested from both WT and TG mice at day 3 and 21 after limb ischaemia. Healthy and age-matched mice without limb ischaemia were used as control. Red blood cells (RBC) were eliminated using RBC lysis as described. 33 The level of intracellular ROS formation in blood cells after limb ischaemia was determined using the ROS Detection Reagents-FITC (Invitrogen) as described. 34 The cells were incubated with the reagent for 10 minutes at 37°C. The labelled cells were washed twice with PBS and then suspended in warm PBS for analysis using flow cytometry. The fluorescence-positive cells were quantitatively evaluated using an LSRII (BD Bioscience, CA) at a wavelength of 525 nm as described. To evaluate BM and circulating mononuclear cell apoptosis, murine BM and blood was collected at day 3, 7 and 21. After elimination of RBC with RBS lysis, blood cell apoptosis was determined with FACS using the apoptosis kit from BD Pharmingen (CA). The early apoptotic cells were defined as Annexin V FITC positive cells, whereas the late apoptotic cells were characterized as Annexin V FITC and propidium iodide (PI) double-positive cells as described. 45 For BM and blood mononuclear proliferation analysis, mice were injected (ip) with 1 mg BrdU 12 hours before analysis. 46 Cells were permeabilized and stained with anti-BrdU PE-Cy5 using the BrdU Flow Kit as per manufacturer's instruction (559619, BD Biosciences, San Jose, CA). For mononuclear cell proliferation analysis, the BrdU positive BM and blood mononuclear cells were analysed using flow cytometry. 47 For all FACS data, at least 5 × 10 4 cells were counted for each sample with a total of at least 1 × 10 6 cells per sample.
| Statistical analysis
All the data were presented as means ± standard deviation (SD), two way ANOVA (analysis of variance) (PRISM Version 4.0.; GraphPad Software, Inc, San Diego, CA) followed by Bonferroni post-tests was used for comparing the subgroups of data from TG and WT mice to minimize type I error as appropriate for all data. The differences were considered statistically significant when a two-tailed P < 0.05.
| RE SULTS
| Concomitant overexpression of triple antioxidant enzymes significantly enhanced the recovery of blood flow and function of the ischemic limb
The recovery of blood flow and muscle function in the mice following acute hind limb ischaemia was evaluated. There was no measur- 
| Concomitant overexpression of triple antioxidant enzymes effectively preserved the muscle fibres of the ischemic limb
As the induction of limb ischaemia leads to remarkable muscle degeneration, 48 
| Concomitant overexpression of triple antioxidant enzymes effectively prevented intracellular ROS formation after limb ischaemia
It is known that limb ischaemia significantly increases ROS production 49 and the ROS production in BM derived mononuclear cells is associated with the number of EPC. 14 To reduce ischaemia-induced ROS production, a TG mouse model overexpressing the antioxidant enzyme network (AON) with reduced ROS formation was used. 23 As expected, both BM and blood mononuclear cell intracellular ROS were significantly increased in the WT con- The muscle fibres reduced in size and became largely disconnected in the WT control mice with limb ischaemia. CD31 staining showed that capillary density was low in the limb muscle after ischaemia for 3, 7 and 21 days. On the other hand, the muscle fibres appeared to remain long and large, as well as well-connected in the limb muscles at day 21 after ischaemia in the TG mice with concomitant global overexpression of SOD1, SOD3 and Gpx-1. CD31 staining demonstrated that the capillary density remained largely intact (similar to the non-ischemic limb Mean vasscular density F I G U R E 3 Concomitant overexpression of triple antioxidant enzymes effectively inhibited intracellular ROS generation after limb ischaemia. Both bone marrow (BM) and blood intracellular ROS were significantly increased in the WT control mice at day 3 to day 21 after limb ischaemia. The blood and BM intracellular ROS production after limb ischaemia was effectively blocked in the mice overexpressing the antioxidant enzymes. BL: blood. BM: bone marrow. *Day 3 or 21 vs Ctrl, P < 0.05, n = 8; $ Day 21 vs 3, P < 0.05, n = 8; #WT vs TG, P < 0.05, n = 8 All circulating EPC populations in TG mice were significantly increased up to 3 folds at day 21 over the WT mice following hind limb ischaemia ( Figure 5 ). And the ischaemia-induced ROS production was also inhibited by TG mice (Figure 3) . The blood c-Kit
population was elevated to 6.5 ± 1.13% in the TG mice (4.3 ± 1.1% in WT mice) at day 3 after ischaemia ( Figure 5C ). However, there were no significant differences in the populations of BM EPCs including Figure 4D ).
| Concomitant overexpression of triple antioxidant enzymes inhibited apoptosis and promoted proliferation of bone marrow and circulating mononuclear cells
To further explore the mechanisms on how AON in the TG mice maintained the circulating EPCs at a higher level compared to the WT mice, BM and blood cells were collected at day 3, 7 and 21 following limb ischaemia to analyse the mononuclear cell apoptotic and proliferation rate. As shown in Figure 6 , in the BM, both early 
| D ISSCUSS I ON
In the present study, we demonstrated that limb ischaemia increased ROS production in both circulating and BM mononuclear cells and significantly increased EPCs levels in BM and blood as expected. in the circulating CD34 + /Flk-1 + cell population in mice. 23 On the other hand, fine particulate matter (PM 2.5 ) exposure could lead to a significant increase in ROS production and significant decrease in the population of circulating CD34 + /CD133 + cells that was effectively prevented when ROS formation was inhibited in mice. 56 In the present study, we observed a significantly increased ROS produc- 59 were also reported to promote vascular formation and reduce tissue ischaemia. However, one study showed that infusion of the antioxidant ebselen into WT mice significantly blocked the increase in blood flow and capillary density after ischaemia. 13 Clearly, more studies are needed to address this inconsistent observation in the future. It is known that certain level of ROS could be proangiogenic.
However, excessive levels of ROS lead to vascular disease through direct and irreversible oxidative damage to macromolecules and disruption of redox-dependent vascular wall signalling processes. 60 It is also known that angiogenesis is a complex process and involves a variety of local and systematic factors and ischaemia could increase ROS levels both locally and systematically. In conclusion, our data demonstrated that concomitant overexpression of SOD1, SOD3 and Gpx-1 significantly attenuated ischaemia-induced ROS production and selectively maintained an elevated level of the circulating EPCs, not the bone marrow EPCs, associated with enhanced recovery of blood flow and function of the ischemic limb. Further studies are needed to investigate the mechanisms for the selective beneficial effects of ROS reduction on circulating EPCs.
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